Dr. Matthew P. Goetz
Claim this profileMayo Clinic in Rochester
Studies Breast Cancer
Studies Breast cancer
8 reported clinical trials
11 drugs studied
Area of expertise
1Breast Cancer
Stage IV
ER positive
HER2 negative
2Breast Cancer
Stage IV
Stage III
HER2 negative
Affiliated Hospitals
Clinical Trials Matthew P. Goetz is currently running
Lasofoxifene and Abemaciclib vs Fulvestrant and Abemaciclib
for Breast Cancer
The goal of this clinical trial is to assess the efficacy, safety and tolerability of the combination of lasofoxifene and abemaciclib compared to fulvestrant and abemaciclib for the treatment of pre- and postmenopausal women and men who have previously received ribociclib or palbociclib-based treatment and have locally advanced or metastatic estrogen receptor positive (ER+)/human epidermal growth factor 2 negative (HER2-) breast cancer with an estrogen receptor 1 (ESR1) mutation. The main question the study aims to answer is: • To compare the efficacy of the combination of lasofoxifene and abemaciclib with that of fulvestrant and abemaciclib Participants will receive either receive 5 mg/d of oral lasofoxifene plus oral abemaciclib 150 mg twice a day or the combination of fulvestrant 500 mg intramuscular (IM) on Days 1, 15, and 29 and then once monthly thereafter plus oral abemaciclib 150 mg twice a day.
Recruiting2 awards Phase 312 criteria
MEN2312
for Breast Cancer
This is a first-in-human study of MEN2312, a lysine acetyltransferase 6 (KAT6) inhibitor, in adult participants with advanced breast cancer.
Recruiting1 award Phase 12 criteria
More about Matthew P. Goetz
Clinical Trial Related1 year of experience running clinical trials · Led 8 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Matthew P. Goetz has experience with
- Abemaciclib
- Exemestane
- Goserelin
- (Z)-endoxifen
- Z-Endoxifen Hydrochloride
- Estradiol
Breakdown of trials Matthew P. Goetz has run
Breast Cancer
Breast cancer
Lobular Carcinoma in Situ
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Matthew P. Goetz specialize in?
Matthew P. Goetz focuses on Breast Cancer and Breast cancer. In particular, much of their work with Breast Cancer has involved Stage IV patients, or patients who are ER positive.
Is Matthew P. Goetz currently recruiting for clinical trials?
Yes, Matthew P. Goetz is currently recruiting for 4 clinical trials in Rochester Minnesota. If you're interested in participating, you should apply.
Are there any treatments that Matthew P. Goetz has studied deeply?
Yes, Matthew P. Goetz has studied treatments such as Abemaciclib, Exemestane, Goserelin.
What is the best way to schedule an appointment with Matthew P. Goetz?
Apply for one of the trials that Matthew P. Goetz is conducting.
What is the office address of Matthew P. Goetz?
The office of Matthew P. Goetz is located at: Mayo Clinic in Rochester, Rochester, Minnesota 55905 United States. This is the address for their practice at the Mayo Clinic in Rochester.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.